semaglutide aspiration case report anesthesia 2023 anesthesia - Semaglutideand dentalanesthesia semaglutide Semaglutide Aspiration Case Report Anesthesia 2023: Emerging Risks and Anesthesia Considerations

Semaglutide anesthesiaguidelines The rapidly expanding use of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, for weight loss and type 2 diabetes management has brought to light potential perioperative concerns, particularly regarding anesthesia. Emerging case report literature from 2023 highlights a significant risk of pulmonary aspiration of gastric contents during anesthesia in patients prescribed semaglutideRegurgitation under anesthesia in a fasted patient prescribed .... This article delves into the findings of these reports, exploring the mechanisms behind this risk, and providing insights into necessary anesthesia considerations作者：VNF Queiroz·2023·被引用次数：26—2023;21:1-3. Risk of pulmonaryaspirationduringsemaglutideuse andanesthesiain a fasting patient: acase reportwith tomographic evidence..

Understanding the Risk: Delayed Gastric Emptying and Aspiration

The primary mechanism linked to semaglutide and the increased risk of pulmonary aspiration is its known effect on delaying gastric emptying. By slowing down the rate at which the stomach empties its contents, semaglutide can lead to a larger residual volume of gastric material.2023年7月19日—Thiscase reporthighlights delayed gastric emptying accentuated in an obese, well-controlled T2DM patient takingsemaglutide, posing an increased risk of ... This is particularly concerning in the context of anesthesia, where the normal protective airway reflexes may be suppressed.

Several case report publications in 2023 specifically address this phenomenon. For instance, a case report published in the *Canadian Journal of Anesthesia* in 2023 detailed instances where patients on semaglutide experienced regurgitation under anesthesia. These reports suggest that even when patients adhere to standard fasting protocols, the delayed gastric emptying induced by semaglutide can result in a significant volume of gastric contents remaining in the stomach, increasing the likelihood of aspiration. Another notable study discussed "Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report," underscoring the direct link observed in clinical practice.

The implications of this finding are critical for medical professionals. A reported incident involving a patient experiencing pulmonary aspiration of regurgitated gastric contents during anesthesia serves as a stark reminder of the potential severity.Regurgitation under anesthesia in a fasted patient ... The risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient necessitates heightened vigilance.Regurgitation under anesthesia in a fasted patient ... Furthermore, reports of "two cases of peri-operative regurgitation of gastric contents" in patients taking semaglutide emphasize that this is not an isolated incident.

Anesthesia Guidelines and Recommendations

In light of these emerging concerns, anesthesiologists are increasingly being advised to exercise caution. While a definitive universal guideline on when to stop semaglutide before surgery is still evolving, the consensus points towards a need for careful patient assessment作者：PR Elmati·2025·被引用次数：1—Regurgitation underanesthesiain a fasted patient prescribedsemaglutidefor weight loss: Acase report. Can J Anaesth2023; 70(8): 1397-400.. The American Society of Anesthesiologists (ASA) has been reviewing these risks. Several sources discuss "Semaglutide ASA guidelines" and "Anesthesia considerations for a patient on Semaglutide," indicating active development of best practices.

The anesthesia considerations for patients on semaglutide often involve pre-operative discussions about the risks of delayed gastric emptying and potential aspiration.作者：SR Klein·2023·被引用次数：200—Wereportacasein which the use ofsemaglutidefor weight loss was associated with delayed gastric emptying and intraoperative pulmonary aspiration of ... Some medical professionals recommend withholding semaglutide for a certain period before elective surgery, although the optimal duration is still under investigation. This approach aims to allow for a more predictable and reduced residual gastric volume, thereby mitigating the risk.Pulmonary aspiration of gastric contents in two patients ...

The link between semaglutide and delayed gastric emptying is a recurring theme in the 2023 literature. This effect, while beneficial for glycemic control and weight management, presents a unique challenge in the perioperative setting.Semaglutide, delayed gastric emptying, and intraoperative ... The "Anesthesia 2023" landscape is actively incorporating these new insights.

Broadening the Scope: Other GLP-1 Agonists and Related Searches

While this discussion primarily focuses on semaglutide, it's important to note that other GLP-1 receptor agonists, such as tirzepatide (marketed as Mounjaro), also share similar pharmacokinetic profiles and are being evaluated for their anesthesia implications. Searches for "Mounjaro anesthesia guidelines" and "Tirzepatide anesthesia guidelines" reflect this broader concern within the medical community.

Other related searches highlight the multifaceted nature of these discussions:

* "Semaglutide anesthesia guidelines" points to the ongoing development of specific protocols.

* "Semaglutide and anesthesia for colonoscopy" indicates concerns in specific procedural contexts.

* "When to stop semaglutide before surgery" is a common query among patients and clinicians.CAS Medication Safety Bulletin June 2023

* "Local anesthesia and semaglutide" and "Semaglutide and dental anesthesia" suggest broader inquiries into the drug's interaction with various types of anesthesiaRegurgitation under anesthesia in a fasted patient ....

Conclusion

The 2023 literature, particularly the growing number of case report publications, has brought the risk of pulmonary aspiration associated with semaglutide use under anesthesia to the forefront.concerns for delayed gastric emptying and pulmonary ... The mechanism of delayed gastric emptying caused by semaglutide is a critical factor to consider. As research and clinical experience expand, it is imperative for healthcare providers to stay informed about the latest findings and recommendations to ensure patient safety during surgical and procedural interventions.Risk of pulmonary aspiration during semaglutide use and ... The proactive approach to understanding and managing these risks is paramount in the evolving field of anesthesia.